Archive

Strategy, appointments, major clinical, medical and regulatory advances, and partnerships: you can find all the latest Ipsen Group press releases here.

IPN10200 Neurotoxine à action prolongée Esthétique
MESDOPETAM PD-DIL
MESDOPETAM MP-DIL
Dysport® solution Rides de la Glabelle
IPN10200 Neurotoxine à action prolongée Thérapeutique
IPN59011 Neurotoxine à action prolongée Esth
© Ipsen Pharma, 65 Quai Georges Gorse, 92100 Boulogne-Billancourt, France. All rights reserved - 2023